Cargando…

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

Detalles Bibliográficos
Autores principales: Inusa, B, Hamdy, M, El-Beshlawy, A, Ebeid, F, Kwiatkowski, J, Kanter, J, Williams, S, Lee, D, Temin, N, Fradette, C, Tricta, F, Elalfy, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812121/
http://dx.doi.org/10.1097/01.HS9.0000821428.51427.ac
_version_ 1784644581429608448
author Inusa, B
Hamdy, M
El-Beshlawy, A
Ebeid, F
Kwiatkowski, J
Kanter, J
Williams, S
Lee, D
Temin, N
Fradette, C
Tricta, F
Elalfy, M
author_facet Inusa, B
Hamdy, M
El-Beshlawy, A
Ebeid, F
Kwiatkowski, J
Kanter, J
Williams, S
Lee, D
Temin, N
Fradette, C
Tricta, F
Elalfy, M
author_sort Inusa, B
collection PubMed
description
format Online
Article
Text
id pubmed-8812121
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88121212022-02-18 S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS Inusa, B Hamdy, M El-Beshlawy, A Ebeid, F Kwiatkowski, J Kanter, J Williams, S Lee, D Temin, N Fradette, C Tricta, F Elalfy, M Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8812121/ http://dx.doi.org/10.1097/01.HS9.0000821428.51427.ac Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Presentations
Inusa, B
Hamdy, M
El-Beshlawy, A
Ebeid, F
Kwiatkowski, J
Kanter, J
Williams, S
Lee, D
Temin, N
Fradette, C
Tricta, F
Elalfy, M
S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
title S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
title_full S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
title_fullStr S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
title_full_unstemmed S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
title_short S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
title_sort s115: long-term efficacy and safety of deferiprone for patients with sickle cell disease or other anemias
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812121/
http://dx.doi.org/10.1097/01.HS9.0000821428.51427.ac
work_keys_str_mv AT inusab s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT hamdym s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT elbeshlawya s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT ebeidf s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT kwiatkowskij s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT kanterj s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT williamss s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT leed s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT teminn s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT fradettec s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT trictaf s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias
AT elalfym s115longtermefficacyandsafetyofdeferiproneforpatientswithsicklecelldiseaseorotheranemias